Bayban’s Abbott ABT Stock Holding History

Bayban’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$322K	Sell	3,552 -787	-18%	-$71.8K	0.25%	70
2026 Q1	$445K	Hold	4,339	–	–	0.39%	50
2025 Q4	$544K	Buy	+4,339	New	+$553K	0.48%	42

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bayban's ABT Position: Q2 2026 in Review

Bayban reduced its Abbott (ABT) stake by 18% in Q2 2026, selling an estimated $71.8K and leaving 3,552 shares worth $322K. The position accounts for 0.25% of the portfolio, ranked #70.

Bayban first reported a position in ABT in Q4 2025 and has held it in 3 quarters since. The position peaked at $544K in Q4 2025. 2,837 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

Bayban held 3,552 shares of Abbott worth $322K as of Q2 2026.
Bayban sold 787 Abbott shares in Q2 2026, an estimated $71.8K.
Abbott made up 0.25% of Bayban's portfolio in Q2 2026, its #70 holding.
Bayban first reported a position in Abbott in Q4 2025 and has held it in 3 quarters since.
Bayban's Abbott position peaked at $544K in Q4 2025.
2,837 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.